20:00
FDA to approves Elevar Therapeutics' Rivoceranib + camrelizumab
22/07
Apostas FDA to approves Elevar Therapeutics' Rivoceranib + camrelizumab - 23.07.2026
Eventos populares e notícias desportivas
Main
Line
Useful Links
Polyaposta Line
Selecionar o idioma